SOLENO THERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Soleno Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q2 2024.
  • Soleno Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.9M, a 188% decline year-over-year.
  • Soleno Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$72.6M, a 151% decline year-over-year.
  • Soleno Therapeutics Inc annual Operating Income (Loss) for 2023 was -$41.4M, a 69.6% decline from 2022.
  • Soleno Therapeutics Inc annual Operating Income (Loss) for 2022 was -$24.4M, a 22.6% increase from 2021.
  • Soleno Therapeutics Inc annual Operating Income (Loss) for 2021 was -$31.5M, a 13.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$72.6M -$24.9M -$16.2M -188% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$56.4M -$23.5M -$15M -177% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$41.4M -$13.9M -$8.3M -148% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$33.1M -$10.4M -$4.15M -66.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$28.9M -$8.62M -$1.84M -27.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$27.1M -$8.47M -$2.7M -46.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$24.4M -$5.61M -$2.61M -86.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$21.8M -$6.24M +$2.05M +24.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$23.8M -$6.78M +$4.31M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$28.1M -$5.77M +$3.38M +36.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$31.5M -$3M +$4.96M +62.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$36.5M -$8.29M -$429K -5.46% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$36.1M -$11.1M +$108K +0.97% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$36.2M -$9.16M +$126K +1.36% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$36.3M -$7.96M -$1.21M -17.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$35.1M -$7.86M -$1.72M -28.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$33.4M -$11.2M -$5.57M -99.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$27.8M -$9.28M -$4.3M -86.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$23.5M -$6.75M -$3.22M -91% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$20.3M -$6.13M -$2.26M -58.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$18M -$5.62M -$2.21M -64.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$15.8M -$4.98M -$1.5M -43.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$14.3M -$3.54M +$1.66M +32% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$16M -$3.88M -$1.25M -47.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$14.7M -$3.41M -$445K -15% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$14.3M -$3.48M -$2.1M -153% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$12.2M -$5.2M -$5.4M -2675% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-20
Q3 2017 -$6.77M -$2.63M -$663K -33.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$6.11M -$2.97M -$673K -29.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$5.43M -$1.37M +$2.89M +67.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$8.32M $202K +$3.71M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$12M -$1.97M +$1.22M +38.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$13.2M -$2.3M +$749K +24.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$14M -$4.26M -$1.84M -75.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$12.2M -$3.51M -$1.66M -90% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$10.5M -$3.18M -$1.86M -141% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$8.64M -$3.04M -$1.74M -133% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$6.9M -$2.43M -$1.74M -255% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-08-09
Q4 2014 -$5.16M -$1.85M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$1.32M -$330K -33.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.31M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$684K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q3 2013 -$993K Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.